Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer

Journal:

Science Advances

Published:

2025-06-27

DOI:

10.1126/sciadv.adu5754

Affiliations:

13

Authors:

25

Go to article

Institutions	Authors	Share
University Hospital of Lausanne (CHUV), UNIL, Switzerland	10.900000 10.900000	0.44
LICR Lausanne Branch, Switzerland	7.400000	0.30
University of Geneva (UNIGE), Switzerland	2.700000	0.11
Swiss Institute of Bioinformatics (SIB), Switzerland	1.500000	0.06
Geneva University Hospitals (HUG), Switzerland	1.500000	0.06
Unité Mixte de Recherche RIGHT, France	1.000000	0.04

Interested in Immunology?